This topic contains a solution. Click here to go to the answer

Author Question: A patient is prescribed to receive 90 mcg of levalbuterol (Xopenex) every 4 hours by oral ... (Read 79 times)

jCorn1234

  • Hero Member
  • *****
  • Posts: 545
A patient is prescribed to receive 90 mcg of
 
  levalbuterol (Xopenex) every 4 hours by oral inhalation. The available drug is levalbuterol 45 mcg/puff. How many total puffs will you tell this patient to take daily?
  a. 4 puffs
  b. 8 puffs
  c. 12 puffs
  d. 16 puffs

Question 2

Why are xanthines seldom used to treat asthma now?
 
  a. They increase bronchial secretions at the same time that they induce bronchial dilation.
  b. They have no role in preventing bronchoconstriction or inflammation.
  c. They are all administered intravenously.
  d. They have severe systemic side effects.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

morganmarie791

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

ANS: C

Answer to Question 2

ANS: D




jCorn1234

  • Member
  • Posts: 545
Reply 2 on: Jul 24, 2018
Great answer, keep it coming :)


hollysheppard095

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

For a complete list of videos, visit our video library